. IP 3 also activates cation channels in vascular smooth muscle cells through mechanisms that do not require the stimulation of sarcoplasmic reticulum (SR) Ca 2ϩ release (27, 54). In cerebral artery smooth muscle cells, IP 3 R activation stimulates TRPC3 channels, leading to Na ϩ influx, membrane depolarization, voltage-dependent Ca 2ϩ channel activation, and vasoconstriction (54). Thus IP 3 Rs regulate ion channel activity, Ca 2ϩ signals, and physiological functions in the vasculature. However, despite the functional importance of IP 3 Rs in arterial smooth muscle cells, specific IP 3 R isoforms that are expressed in this cell type and their functional significance are poorly understood.
INOSITOL 1,4,5-trisphosphate (IP 3 ) receptors (IP 3 Rs) are expressed in many cell types and regulate several physiological functions, including development, muscle contraction, cell proliferation, and differentiation (1, 45, 47, 56) . In vascular smooth muscle cells, IP 3 Rs modulate vasoconstriction and proliferation by altering spatial and temporal properties of local and global Ca 2ϩ signals (51, 53) . Vasoconstrictors, including norepinephrine, phenylephrine, UTP, and vasopressin, stimulate Ca 2ϩ waves and Ca 2ϩ oscillations in smooth muscle cells of portal vein, rat tail, mesenteric and cerebral arteries, and cultured A7r5 smooth muscle cells (5, 7, 21, 23, 29) . Vasoconstrictors also elevate arterial smooth muscle cell global intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and induce vasoconstriction by stimulating IP 3 Rs (7, 43, 54) . IP 3 also activates cation channels in vascular smooth muscle cells through mechanisms that do not require the stimulation of sarcoplasmic reticulum (SR) Ca 2ϩ release (27, 54) . In cerebral artery smooth muscle cells, IP 3 R activation stimulates TRPC3 channels, leading to Na ϩ influx, membrane depolarization, voltage-dependent Ca 2ϩ channel activation, and vasoconstriction (54) . Thus IP 3 Rs regulate ion channel activity, Ca 2ϩ signals, and physiological functions in the vasculature. However, despite the functional importance of IP 3 Rs in arterial smooth muscle cells, specific IP 3 R isoforms that are expressed in this cell type and their functional significance are poorly understood.
Three IP 3 R isoforms, designated IP 3 R1, IP 3 R2, and IP 3 R3, are encoded by distinct genes (6, 37) . IP 3 R isoform expression varies widely between different cell types. Cerebellar Purkinje neurons express predominantly IP 3 R1, pancreatic ␤-cells primarily express IP 3 R3, and cardiac myocytes express IP 3 R2 (14, 48) . All three IP 3 R isoforms are expressed in whole aorta, mesenteric and basilar arteries, and cultured aortic smooth muscle cells (17, 56) . In primary cultured portal vein smooth muscle cells, IP 3 R1 and IP 3 R2 were detected by immunofluorescence, whereas IP 3 R3 was absent (32) . In contrast, in primary cultured rat ureter smooth muscle cells and cultured A7r5 cells, IP 3 R1 and IP 3 R3 were expressed and IP 3 R2 was absent (32, 51) .
IP 3 R isoforms may also regulate vascular smooth muscle Ca 2ϩ signaling in a cell-specific manner. IP 3 R2 activation contributes to ACh-induced Ca 2ϩ oscillations in cultured portal vein smooth muscle cells (32) . In contrast, IP 3 R1 was required for ACh-induced Ca 2ϩ elevations in cultured portal vein smooth muscle cells (32) , ATP-induced Ca 2ϩ transients in cultured aortic smooth muscle cells (56) , and vasopressinevoked Ca 2ϩ release and capacitative Ca 2ϩ entry in cultured A7r5 smooth muscle cells (51) . These studies suggest that IP 3 R isoform expression may differ between smooth muscle cell types, leading to tissue-specific regulation of intracellular Ca 2ϩ signaling.
The major goal of this study was to determine the functional significance of IP 3 R isoforms that are expressed in smooth muscle cells of resistance-size cerebral arteries. We demonstrate that all three IP 3 R isoforms are expressed in rat cerebral artery smooth muscle cells and that IP 3 R1 is, by far, the most abundant. We also show that IP 3 R1 suppression using antibodies and short hairpin RNA (shRNA) reduces UTP-induced elevations in Ca 2ϩ wave frequency and global [Ca 2ϩ ] i , cation current (I cat ) activation, and vasoconstriction. These data identify IP 3 R1 as the principal molecular and functional IP 3 R isoform in cerebral artery smooth muscle cells. verified by using dissociation curve analysis. Relative IP3R isoform mRNA expression was calculated from the difference between fluorescence threshold (Ct) values (⌬Ct) of each IP3R isoform sample using the ⌬C t method.
Immunoblotting. Rat whole brain or cerebral arteries were homogenized in Laemmli sample buffer (2.5% SDS, 10% glycerol, 0.01% bromphenol blue, and 5% ␤-mercaptoethanol in 100 mM Tris ⅐ HCl, pH 6.8) and centrifuged at 10,000 g for 10 min. Proteins (30 g/lane) were separated by 4 -15% gradient SDS-polyacrylamide gels and transferred onto polyvinylidene difluoride membranes using a Mini Trans Blot Cell (Bio-Rad, Hercules, CA). Membranes were then incubated with polyclonal anti-IP3R1 (1:1,000 dilution; Alomone Labs), IP 3R2 (1:500 dilution; Santa Cruz Biotechnology), or monoclonal anti-IP3R3 (1:500 dilution, BD Transduction Laboratories) antibodies overnight at 4°C in Tris-buffered solution (TBS) with 0.1% Tween 20 (TBS-T) and 5% nonfat dry milk. After three washes with TBS-T, membranes were incubated for 1 h with horseradish peroxidase-conjugated secondary antibody (1:10,000 dilution; Pierce Biotechnology) and then washed with TBS-T. Membranes were developed using enhanced chemiluminescence (Amersham, Arlington Heights, IL). Membranes were reprobed with monoclonal anti-actin antibody (1:10,000 dilution; Chemicon International) and then with horseradish peroxidase-conjugated anti-mouse IgG. Band intensities were quantified by digital densitometry using Quantity One version 4.4.1 software. IP3R isoform band intensity was normalized to actin.
Immunofluorescence. Freshly isolated smooth muscle cells were fixed with 3.7% paraformaldehyde in PBS (Invitrogen, Carlsbad, CA) for 15 min and permeabilized with 0.1% Triton X-100 for 1 min at room temperature. After 1 h of incubation in PBS containing 5% BSA, smooth muscle cells were treated overnight at 4°C with antibodies to IP 3R1 (UC Davis/NINDS/NIMH NeuroMab Facility). IP 3R2 (Affinity Bio), or IP3R3 (BD Transduction Laboratories), each at a dilution of 1:100 in PBS containing 5% BSA. After they were washed and blocked with 10% goat serum, smooth muscle cells were incubated with secondary antibodies (1:100 dilution; Invitrogen-Molecular Probes) as follows: goat anti-mouse IgG with Alexa Fluor 546 for IP 3R1, goat anti-rabbit IgG with Alexa Fluor 488 for IP3R2, or anti-mouse IgG2a with Alexa Fluor 555 for IP 3R3. The cells were washed and mounted, and fluorescence images were obtained using a Zeiss LSM Pascal scanning confocal microscope. Negative controls were prepared by omission of primary antibodies. IP 3R1 knockdown. Two different IP3R1 silencing vectors were constructed by GenScript (Piscataway, NJ) using pRNA-U6.1/Neo as a backbone plasmid to encode shRNA targeting IP 3R1. The vectors encode CGGTCGAAATGTCCAGTATA (IP3R1shV1) or GCAG-CAACGTGATGAGATCTA (IP3R1shV2). A pRNA-U6.1/Neo vector that encodes a scrambled sequence (TGAACATCAGTGCTAG-GTTAC) was used as a control (IP3R1scrm). To deliver plasmids into arterial wall cells, reverse permeabilization was used (54) . IP3R1shV1 (10 g/ml) was used for Western blotting, patch clamp, and diameter measurements, and IP3R1shV1 (5 g/ml) ϩ IP3R1shV2 (5 g/ml) was used for Western blotting and Ca 2ϩ imaging experiments, with IP3R1scrm (10 g/ml) as control for each.
Patch-clamp electrophysiology. Icat was measured in the presence or absence of UTP (30 M) using the conventional whole cell patch-clamp configuration (Axopatch 200B, Clampex 8.2). The pipette solution contained (in mM) 140 CsCl, 10 HEPES, 10 glucose, 5 MgATP, and 5 EGTA (with pH adjusted to 7.2 with CsOH), with free Ca 2ϩ adjusted to 100 nM using Ca 2ϩ -sensitive (catalog no. 476041, Corning) and reference (catalog no. 476370, Corning) electrodes. Bath solution contained (in mM) 140 NaCl, 1.8 CaCl2, 1.2 MgCl2, 10 HEPES, and 10 glucose (with pH adjusted to 7.4 with NaOH). For experiments studying Icat regulation in myocytes treated with IP3R1 scrambled and suppression vectors, thapsigargin (100 nM) was included in the pipette solution to induce SR Ca 2ϩ depletion. Where appropriate, IP3R1 antibody (Alomone Labs) or a denatured IP3R1 antibody control (95°C, 10 min) was included in the pipette solution (1:100 dilution). Whole cell currents were measured by applying 940-ms voltage ramps between Ϫ120 and ϩ20 mV with a holding potential of Ϫ40 mV. Current amplitude was analyzed offline using Clampfit 9.2.
Laser-scanning confocal Ca 2ϩ imaging. Cerebral artery segments were cannulated and incubated in the dark with fluo-4 AM (10 M) and 0.05% Pluronic F-127 for 1 h. Intracellular Ca 2ϩ signals in cerebral artery smooth muscle cells were imaged using a Noran Oz laser-scanning confocal microscope, as described previously (11) . Fluo-4 AM was excited with 488-nm light, and emitted light Ͼ510 nm was collected. Images (112.6 ϫ 105.6 m) were acquired at a rate of 30 s Ϫ1 . Under each condition, at least two different representative areas of the same arterial segment were each scanned for 10 s. The same area of artery was scanned only once to avoid any laser-induced changes in Ca 2ϩ signaling, and the effects of pharmacological agents were measured in paired experiments. Ca 2ϩ wave frequency and global [Ca 2ϩ ]i were analyzed offline using custom software kindly provided by Dr. M. T. Nelson (University of Vermont), as previously described (11 (10) .
Fura-2 imaging. IP3R1scrm-or IP3R1shV-treated cerebral artery segments were incubated in HEPES-buffered solution (in mM: 134 NaCl, 6 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, with pH adjusted to 7.4 with NaOH) containing fura-2 AM (5 M) and 0.05% Pluronic F-127 for 30 min and then washed for 15 min. Fura-2 was alternately excited at 340 or 380 nm using a personal computer-driven hyperswitch (Ionoptix, Milton, MA). Background-corrected ratios were collected every 1 s at 510 nm using a photomultiplier tube. SR Ca 2ϩ load was estimated by measuring the amplitude of caffeine (10 mM)-induced [Ca 2ϩ ]i transients, as we described previously (11) . Pressurized artery diameter measurement. Endothelium-denuded cerebral artery segments were cannulated at each end in a perfusion chamber. The chamber was continuously perfused with PSS and maintained at 37°C. Intravascular pressure was altered using an attached reservoir and monitored using a pressure transducer. Wall diameter was measured at 1 Hz using a charge-coupled device camera and the edge-detection function of IonWizard (Ionoptix). Pharmacological agents were applied via chamber perfusion. Passive diameter was determined by applying Ca 2ϩ -free PSS supplemented with 5 mM EGTA. The magnitude of myogenic tone was calculated using the following equation: myogenic tone (%) ϭ (1 Ϫ active diameter/ passive diameter) ϫ 100.
Reagents. Unless otherwise specified, all reagents were purchased from Sigma-Aldrich (St. Louis, MO). Fluo-4 AM, fura-2 AM, and Pluronic F-127 were purchased from Molecular Probes (Eugene, OR), and papain was obtained from Worthington Biochemical (Lakewood, NJ).
Statistical analysis. Values are means Ϯ SE. Student's t-test and Student-Newman-Keuls test were used for comparison of paired or unpaired data and multiple data sets, respectively. P Ͻ 0.05 was considered significant. (Fig. 1, A and B) . UTP also elevated mean global [Ca 2ϩ ] i from 193 nM (10) to ϳ318 nM (Fig. 1C) . 2-Aminoethoxydiphenyl borate (2-APB) and xestospongin C (XeC), IP 3 R blockers both prevented UTP-induced Ca 2ϩ wave activation (Fig. 1, A and B) . The mean UTPinduced global [Ca 2ϩ ] i elevation was reduced by ϳ54% by XeC and blocked by 2-APB (Fig. 1C) . XeC did not significantly change spontaneous Ca 2ϩ wave frequency (0.07 Ϯ 0.05 Hz, n ϭ 4, P Ͼ 0.05), whereas 2-APB abolished these events (0 Ϯ 0 Hz, n ϭ 4, P Ͻ 0.05). These data indicate that IP 3 (9) . Transcripts for all three IP 3 R isoforms were amplified using conventional RT-PCR ( Fig. 2A) . Quantitative real-time PCR indicated that IP 3 R1 mRNA was the most abundant, at ϳ82% of total IP 3 R message (Fig. 2B) .
RESULTS

IP 3 R stimulation contributes to UTP-induced
Western blotting was performed using IP 3 R isoform-specific antibodies to detect proteins in rat cerebral artery lysate. Consistent with data obtained from RT-PCR experiments, protein bands for IP 3 R1, IP 3 R2, and IP 3 R3 were detected in whole brain and rat cerebral artery lysates, with the IP 3 R1 band the most prominent and IP 3 R2 the least intense (Fig. 2C) . Immunofluorescence also identified IP 3 R1, IP 3 R2, and IP 3 R3 protein in freshly isolated cerebral artery smooth muscle cells (Fig. 2D) . Collectively, these data indicate that IP 3 R1 is the most abundant IP 3 R isoform expressed in rat cerebral artery smooth muscle cells.
IP 3 R1 knockdown using shRNA in intact cerebral arteries. Two different silencing vectors (IP 3 R1shV1 and IP 3 R1shV2) were constructed to express IP 3 R1-specific shRNA. IP 3 R1shV1 and IP 3 R1shV2 target exons 32 and 24, respectively, in IP 3 R1. ]i were calculated from a control value previously determined using fura-2 (10). Values are means Ϯ SE; n ϭ 27, 13, 4, and 9 for control, UTP, UTP ϩ 2-APB, and UTP ϩ XeC, respectively. *P Ͻ 0.05 vs. control. #P Ͻ 0.05 vs. UTP.
A vector that encodes scrambled shRNA (IP 3 R1scrm) was used as a control. Reversible permeabilization was used to introduce IP 3 R1scrm, IP 3 R1shV1, IP 3 R1shV2, and IP 3 R1shV1 ϩ IP 3 R1shV2 into intact cerebral arteries. Western blot analysis indicated that IP 3 R1shV1 and IP 3 R1shV2 reduced mean IP 3 R1 protein to ϳ67 and 53%, respectively, of that in arteries treated with IP 3 R1scrm (Fig. 3) . Insertion of both IP 3 R1shV1 ϩ IP 3 R1shV2 decreased mean IP 3 R1 expression to ϳ48% of that in arteries treated with IP 3 R1scrm (Fig. 3) . IP 3 R1 knockdown did not alter IP 3 R3 protein, as determined by reprobing membranes with an IP 3 R3-selective antibody (Fig. 3B) ] i elevation by ϳ61% (Fig. 4, A (54) . Therefore, we studied the importance of IP 3 R1 for this response. Inclusion of an anti-IP 3 R1 antibody in the pipette solution reduced mean baseline I cat density by ϳ70% and attenuated the UTP-induced I cat elevation by ϳ85% compared with a denatured antibody control (Fig. 5) . I cat regulation was also studied in smooth muscle cells isolated from arteries in which IP 3 R1 expression was reduced using shRNA. Baseline current density in IP 3 R1scrm and IP 3 R1shV were similar [Ϫ3.8 Ϯ 0.7 pA/pF (n ϭ 11) and Ϫ3.9 Ϯ 1.1 pA/pF (n ϭ 4), respectively, P Ͼ 0.05; Fig. 6 ]. However, UTP-induced I cat activation was reduced by ϳ87% in IP 3 R1shV-treated smooth muscle cells compared with cells (Fig. 6 ). These data indicate that IP 3 R1 is required for UTP-induced I cat activation in cerebral artery smooth muscle cells.
IP 3 R1 knockdown attenuates UTP-induced vasoconstriction in arteries with intact and depleted SR Ca
2ϩ
. To investigate physiological functions of IP 3 R1, diameter regulation of pressurized (20 mmHg) endothelium-denuded arteries was studied. IP 3 R1 knockdown did not alter baseline myogenic tone [23 Ϯ 1.8% (n ϭ 6) vs. 19 Ϯ 0.7% for scrambled control (n ϭ 6), P Ͼ 0.05] but reduced mean UTP (1 M)-induced constriction by ϳ52% compared with scrambled control (Fig. 7) . Thapsigargin (100 nM-1 M), at concentrations that deplete SR Ca 2ϩ in cerebral artery smooth muscle cells (54), did not alter arterial diameter (Fig. 7) . In SR Ca 2ϩ -depleted arteries, IP 3 R1 knockdown also reduced mean UTP-induced vasoconstriction by ϳ57% (100 nM thapsigargin) and 62% (1 M thapsigargin). These data indicate that IP 3 R1 activation is essential for UTP-induced vasoconstriction in cerebral arteries.
DISCUSSION
We have investigated the relative expression and physiological functions of IP 3 R isoforms in cerebral artery smooth muscle cells. We provide novel evidence that 1) IP 3 R1 is the predominant IP 3 R isoform, 2) IP 3 R1 activation is required for UTP-induced I cat activation, Ca 2ϩ wave stimulation, and global [Ca 2ϩ ] i elevation, and 3) IP 3 R1 activation contributes to UTP-induced vasoconstriction in arteries with intact and depleted SR Ca 2ϩ . Previous studies detected IP 3 R isoforms that are expressed in the vasculature by performing RT-PCR and immunofluorescence on whole vessels or cultured vascular smooth muscle cells (17, 32, 51, 56) . These studies suggested that all three IP 3 R isoforms are expressed in cultured aortic smooth muscle cells, whole aorta, and mesenteric and basilar arteries, whereas IP 3 R3 was absent in cultured portal vein smooth muscle cells (17, 32, 51, 56) . Using quantitative RT-PCR, we show that all three IP 3 R isoforms are expressed in freshly isolated, selected cerebral artery smooth muscle cells, with IP 3 R1 message being the most abundant. Immunofluorescence also identified all three IP 3 R isoforms in isolated smooth muscle cells, and Western blotting of cerebral artery lysate supported the quantitative PCR data suggesting that IP 3 R1 was the most abundant protein. These data indicate that IP 3 R1 is by far the most prevalent IP 3 R isoform expressed in cerebral artery smooth muscle cells.
UTP-induced phospholipase C activation elevates diacylglycerol (DAG), leading to PKC activation, and increases IP 3 , leading to IP 3 R activation (35, 44 waves (7, 15, 16, 18) . One model suggests that ryanodine receptor (RyR) channel and IP 3 R activation is required for Ca 2ϩ wave generation and propagation (7, 15, 16, 26) . In this scenario, IP 3 acts as a primer to trigger Ca 2ϩ release through SR IP 3 Rs. Released Ca 2ϩ then stimulates further Ca 2ϩ release by activating RyR channels, and waves proceed independently of IP 3 Rs. Another proposal suggests that IP 3 R activation alone is sufficient to initiate and propagate waves through Ca 2ϩ -induced Ca 2ϩ release (18, 26) . Both concepts indicate that IP 3 Rs are required for Ca 2ϩ wave generation. In cultured human coronary artery smooth muscle cells, IP 3 generation and subsequent IP 3 R activation are required for UTP-induced SR Ca 2ϩ release (44) . Our data obtained using pharmacological blockers, antibodies, and protein knockdown indicate that IP 3 R1 is required for UTP-induced Ca 2ϩ wave generation and propagation. IP 3 R1 knockdown did not change SR Ca 2ϩ load, which would have indirectly affected Ca 2ϩ wave frequency (23, 30) . Thus data suggest that IP 3 R1 knockdown inhibits Ca 2ϩ waves by reducing the number of IP 3 R1 channels that contribute to these signaling events. Intracellular IP 3 concentration should be low in the absence of exogenous receptor agonists, although UTP may be released from endothelial cells under resting conditions, which may generate additional IP 3 (24, 25, 38) . Since IP 3 R1 knockdown and XeC did not alter baseline Ca 2ϩ wave frequency in the absence of UTP, our data suggest that the contribution of IP 3 to Ca 2ϩ waves in the absence of agonists is small. These data support previous evidence that spontaneous Ca 2ϩ waves occur due to RyR channel activation and that RyR channel activation alone can produce Ca 2ϩ waves (8, 19) . In contrast to effects of XeC and IP 3 R knockdown, 2-APB abolished spontaneous Ca 2ϩ waves. This effect may occur as a result of nonspecific actions of 2-APB on mitochondria and nonselective cation channels, in addition to IP 3 R inhibition (33) . In cultured portal vein smooth muscle cells, IP 3 R2 activation was required for ACh-induced global Ca 2ϩ oscillations, whereas targeting of IP 3 R1 had no effect on these Ca 2ϩ signals (32) . These different findings raise the possibility that IP 3 Rs exhibit variable expression profiles and physiological functions in smooth muscle cells of anatomically different vessels and in cultured versus noncultured smooth muscle cells. Collectively, data presented here and in our previous study indicate that IP 3 R1 activation contributes to agonist-induced I cat activation in cerebral artery smooth muscle cells (54) . TRPC channels, including TRPC1, TRPC3, TRPC5, TRPC6, and TRPC7, are expressed in vascular smooth muscle cells and may contribute to I cat (2, 12, 28, 36, 39, 40, 54) . In cerebral artery smooth muscle cells, TRPC3 channel knockdown attenuated endothelin-1-and IP 3 -induced [Ca 2ϩ ] i elevation and constriction, indicating that this isoform is a major contributor to the IP 3 R-induced I cat in this cell type (54) . The mechanism by which IP 3 R activation stimulates I cat in arterial smooth muscle cells is unclear. Studies using protein overexpression have demonstrated that a consensus sequence present on the COOH terminus of all TRPC channel isoforms recognizes an NH 2 -terminal binding domain found in all IP 3 R isoforms (46) . It has been proposed that physical coupling of these two domains removes inhibitory calmodulin from the TRPC channel COOH terminus, leading to channel activation (46, 55) . Whether a similar coupling mechanism underlies IP 3 R regulation of I cat and TRPC3 channels in arterial smooth muscle cells remains to be determined but is one possibility.
Our data indicate that IP 3 R1 suppression with antibodies or shRNA attenuated UTP-induced I cat activation by ϳ85%. This level of inhibition is large, given that UTP-induced phospholipase C activation also elevates DAG, and DAG and 1-oleoyl- 2-acetyl-sn-glycerol (OAG), a DAG analog, activated I cat in rat cerebral and rabbit coronary artery smooth muscle cells, portal vein smooth muscle cells, and cells overexpressing TRPC channels (3, 20, 34, 42) . In cerebral artery smooth muscle cells, PKC activation stimulates an I cat by increasing the apparent micromolar Ca 2ϩ sensitivity of TRPM4 channels (13, 42) . In our patch-clamp experiments, EGTA was used to clamp free Ca 2ϩ at a physiological concentration of 100 nM. Therefore, UTP-induced PKC activation would not be expected to activate TRPM4 channels, and the strong inhibitory effect of IP 3 R1 inhibition on UTP-induced I cat may be due to an effect on TRPC channels alone. However, PKC regulation of TRPC channels is complex, with studies reporting activation, inhibition, or no effect on TRP channels, including those using smooth muscle cells from a variety of blood vessels (4, 34, 41, 49, 50) . In rabbit coronary artery smooth muscle cells, IP 3 potentiated DAG-induced I cat activation, and heparin blocked this activation, indicating that IP 3 Rs mediated this response (34) . In cerebral artery smooth muscle cell inside-out patches, IP 3 and OAG did not activate cation channels, and OAG did not facilitate IP 3 -induced cation channel activation (54) release (22) . Since SR Ca 2ϩ depletion did not alter UTPinduced vasoconstriction, our data suggest that SR Ca 2ϩ release and, thus, Ca 2ϩ waves do not contribute to UTP-induced vasoconstriction. These data support our previous observation that SR Ca 2ϩ release does not contribute to IP 3 -induced vasoconstriction at low pressure (54) . We have also shown that elevating pressure to 60 mmHg increases the contribution of SR Ca 2ϩ release to IP 3 -induced vasoconstriction (54). Conceivably, vasoconstrictor-induced Ca 2ϩ waves may directly contribute to contraction at higher pressures.
Physiological functions of IP 3 R2 and IP 3 R3 were not directly investigated in the present study. By comparing effects of XeC, a blocker of all IP 3 R isoforms, and those of IP 3 R1 knockdown and antibodies, data suggest that IP 3 R1 is the principal molecular isoform mediating UTP-induced I cat activation, Ca 2ϩ wave stimulation, and contraction in cerebral artery smooth muscle cells. Partial IP 3 R1 knockdown almost completely blocked UTP-induced I cat and Ca 2ϩ wave activation and partially attenuated vasoconstriction. IP 3 R2 and IP 3 R3 are expressed and therefore, these proteins are highly likely to perform physiological functions in arterial myocytes. We do not rule out physiological functions for IP 3 R2 and IP 3 R3. However, our data indicate a principal function for IP 3 R1 in mediating these responses.
In summary, the present study provides evidence that all three IP 3 R isoforms are expressed in rat cerebral artery smooth muscle cells and that IP 3 R1 is the most abundant subtype. We also show that IP 3 R1 activation contributes to UTP-induced I cat activation, Ca 2ϩ wave stimulation, global [Ca 2ϩ ] i elevation, and vasoconstriction. These data indicate that IP 3 R1 activation is necessary for UTP-induced vasoconstriction.
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